Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Wunderle

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
BMC Medical Imaging|July 31, 2020
Breast MRI texture analysis for prediction of BRCA-associated genetic riskGeorgia Vasileiou, Maria J Costa, Christopher Long, et al.
Scientific Reports|March 22, 2020
RANKL and OPG and their influence on breast volume changes during pregnancy in healthy womenMarius Wunderle, Matthias Ruebner, Lothar Häberle, et al.
Geburtshilfe Und Frauenheilkunde|June 9, 2018
Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart DataMarius Wunderle, Gregor Olmes, Naiba Nabieva, et al.
Therapeutic Advances in Medical Oncology|September 30, 2020
Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setupJulius Emons, Peter A Fasching, Marius Wunderle, et al.
European Journal of Medical Research|September 28, 2023
Predicting mammographic density with linear ultrasound transducersAnnika Behrens, Peter A Fasching, Eva Schwenke, et al.
Breast Care (Basel, Switzerland)|April 26, 2019
Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot StudyMichael P Lux, Julius Emons, Mayada R Bani, et al.
Breast Cancer Research and Treatment|May 5, 2018
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patientsMarius Wunderle, Paul Gass, Lothar Häberle, et al.
Breast Care (Basel, Switzerland)|June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesFranziska Würfel, Ramona Erber, Hanna Huebner, et al.
International Journal of Molecular Sciences|August 12, 2022
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World SettingRamona Erber, Miriam Angeloni, Robert Stöhr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on PrognosisPeter A Fasching, Siddhartha Yadav, Chunling Hu, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
BMC Medical Imaging|July 31, 2020
Breast MRI texture analysis for prediction of BRCA-associated genetic riskGeorgia Vasileiou, Maria J Costa, Christopher Long, et al.
Scientific Reports|March 22, 2020
RANKL and OPG and their influence on breast volume changes during pregnancy in healthy womenMarius Wunderle, Matthias Ruebner, Lothar Häberle, et al.
Geburtshilfe Und Frauenheilkunde|June 9, 2018
Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart DataMarius Wunderle, Gregor Olmes, Naiba Nabieva, et al.
Therapeutic Advances in Medical Oncology|September 30, 2020
Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setupJulius Emons, Peter A Fasching, Marius Wunderle, et al.
European Journal of Medical Research|September 28, 2023
Predicting mammographic density with linear ultrasound transducersAnnika Behrens, Peter A Fasching, Eva Schwenke, et al.
Breast Care (Basel, Switzerland)|April 26, 2019
Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot StudyMichael P Lux, Julius Emons, Mayada R Bani, et al.
Breast Cancer Research and Treatment|May 5, 2018
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patientsMarius Wunderle, Paul Gass, Lothar Häberle, et al.
Breast Care (Basel, Switzerland)|June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesFranziska Würfel, Ramona Erber, Hanna Huebner, et al.
International Journal of Molecular Sciences|August 12, 2022
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World SettingRamona Erber, Miriam Angeloni, Robert Stöhr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on PrognosisPeter A Fasching, Siddhartha Yadav, Chunling Hu, et al.
Pageof 4